Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation?
Morales
Jose M
JM
Hospital 12 de Octubre Renal Transplant Unit Nephrology Department, Madrid 28001, Spain. jmorales@h12o.es
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use*; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007211:Indoles / Q000627:therapeutic use*; D016030:Kidney Transplantation; D011183:Postoperative Complications / Q000517:prevention & control*; D013997:Time Factors
D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D000077340:Fluvastatin